MilliporeSigma Webinars
-
The Closed Processing Advantage: Optimizing Biopharma Facilities
11/16/2023
Explore the evolving landscape of biopharma facility design and operations, including key market trends, closed processing benefits, and industry efforts to harmonize guidance and best practices.
-
Accelerate Development And De-Risk Gene Therapy Manufacturing
10/20/2023
Join viral vector process and analytical development experts as they showcase strategies for developing robust processes and analytics for efficient and de-risked manufacturing.
-
From Myth To Mastery: Unveiling The Secrets Of Virus Bank Manufacturing
9/12/2023
It is crucial to start off your product development right. Here, you will learn how to best approach virus bank production. Review best practices, how to overcome common obstacles, and more.
-
Kick It Off Right: A Successful Cell Bank Manufacture
9/12/2023
Learn about best practices for cell bank manufacturing, how to get the most out of your cell bank, the future of closed processing in line with Annex 1, and more.
-
Industry-Leading Lentiviral Titers Through Optimized Production Technology
8/28/2023
See how VirusExpress' technology was optimized to provide industry-leading lentiviral titer and a streamlined approach to accelerate development timelines and de-risk manufacturing.
-
Characterizing AAV Encapsidated Nucleic Acid Sequences Using NGS
8/11/2023
Here, we discuss the characterization of several representative AAV molecules using next-generation sequencing (NGS), including the sequencing process, bioinformatic analysis, and representative results.
-
Maximizing The Value Of Your AAV Using Small Volume AAV Testing
8/11/2023
Learn about MilliporeSigma's approach to method development, where more than one AAV critical quality attribute can be measured within a single analytical run.
-
How To Bring Your LNP Formulation To Clinical/Commercial Manufacturing
7/26/2023
To enable the development of next-generation lipid-based drug delivery systems, expertise and manufacturing capabilities are critical.
-
Streamlining Viral Vector Development And Gene Therapy Manufacturing
7/19/2023
Explore solutions for gene therapy production from experts, as they highlight the key features of a GMP manufacturing facility, including its technologies and infrastructure, through a virtual tour.
-
Vaccine Journey: Bench To Market
7/19/2023
Vaccines are entering a new era. Gain insight into the market trends, projections, challenges, and potential solutions around the future of vaccine manufacturing.